Sai, Kimie
Nakatani, Eiji
Iwama, Yasuhiro
Hiraoka, Shuichi
Tohkin, Masahiro
Uyama, Yoshiaki
Saito, Yoshiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19mk0101083, JP19mk0101083, JP19mk0101083, JP19mk0101083)
Article History
Received: 30 September 2020
Accepted: 18 November 2020
First Online: 3 January 2021
Compliance with Ethical Standards
:
: This study was conducted through collaboration between the project team and pharmaceutical companies. Drs. Sai, Tohkin, Uyama and Saito report grants from AMED (JP19mk0101083) during the conduct of the study. Mr. Iwama and Dr. Hiraoka are employed by Meiji Seika Pharma Co., Ltd. (Tokyo, Japan). Dr. Tohkin reports grants from Grant-in-Aid for Scientific Research (C), grants from Food Safety Commission, grants from AI-SHIPS project, outside the submitted work; No other conflicting interests exist.
: This study was approved by all collaborating companies and the ethics committee of NIHS (NIHS approval No. 295-2).